|
Volumn 11, Issue SUPPL. 1, 2006, Pages
|
Management of bone disease, calcium, phosphate and parathyroid hormone
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM HYDROXIDE;
CALCIMIMETIC AGENT;
CALCITRIOL;
CALCIUM;
CALCIUM ACETATE;
CALCIUM CARBONATE;
CALCIUM DERIVATIVE;
CALCIUM KETOGLUTARATE;
CINACALCET;
CITRATE CALCIUM;
DOXERCALCIFEROL;
FALECALCITOL;
FERRIC CITRATE;
FLECAINIDE;
LANTHANUM CARBONATE;
MAGNESIUM CARBONATE;
MAXICALCITOL;
PARATHYROID HORMONE;
PARICALCITOL;
PHOSPHATE;
PHOSPHATE BINDING AGENT;
SEVELAMER;
THIORIDAZINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
VITAMIN D;
VITAMIN D DERIVATIVE;
ARTERY CALCIFICATION;
BLOOD VESSEL CALCIFICATION;
BONE DISEASE;
CALCIUM BLOOD LEVEL;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
GASTROINTESTINAL SYMPTOM;
HEMODIALYSIS;
HUMAN;
HYPERCALCEMIA;
HYPERPARATHYROIDISM;
HYPERPHOSPHATEMIA;
MYALGIA;
NAUSEA;
NONHUMAN;
PATIENT COMPLIANCE;
PATIENT MONITORING;
PERIPHERAL EDEMA;
PERITONEAL DIALYSIS;
PHOSPHATE BLOOD LEVEL;
PRIORITY JOURNAL;
SECONDARY HYPERPARATHYROIDISM;
TREATMENT OUTCOME;
VOMITING;
ARTICLE;
BLOOD;
KIDNEY FAILURE;
PRACTICE GUIDELINE;
RENAL REPLACEMENT THERAPY;
BONE DISEASES;
CALCITRIOL;
CALCIUM;
HUMANS;
KIDNEY FAILURE;
PARATHYROID HORMONE;
PERITONEAL DIALYSIS;
PHOSPHATES;
RENAL DIALYSIS;
VITAMIN D;
|
EID: 33646249959
PISSN: 13205358
EISSN: 14401797
Source Type: Journal
DOI: 10.1111/j.1440-1797.2006.00508.x Document Type: Conference Paper |
Times cited : (33)
|
References (0)
|